Affect Therapeutics Inc

Contact Information
2385 South 179th Street Unit C, Office #5, New Berlin, Wisconsin 53146, United States
Detailed Information

Affect Therapeutics Inc

    Services:
    Assessment/Pre-treatment

    • Screening for tobacco use
    • Screening for mental disorders
    • Comprehensive substance use assessment
    • Screening for substance use
    • Interim services for clients

    External Opioid Medications Source

    • Other contracted prescribing entity
    • No formal relationship with prescribing entity

    License/Certification/Accreditation

    • State Substance use treatment agency
    • Commission on Accreditation of Rehabilitation Facilities (CARF)
    • State mental health department

    Gender Accepted

    • Male
    • Female

    Type of Opioid Treatment

    • Accepts clients using MAT but prescribed elsewhere
    • Relapse prevention with naltrexone

    Education and Counseling Services

    • Substance use disorder education
    • Group counseling
    • Individual counseling
    • Smoking/vaping/tobacco cessation counseling

    Age Groups Accepted

    • Young Adults
    • Adults

    Service Setting (e.g., Outpatient, Residential, Inpatient, etc.)

    • Outpatient methadone/buprenorphine or naltrexone treatment
    • Regular outpatient treatment
    • Intensive outpatient treatment
    • Outpatient

    External Source of Medications Used for Alcohol Use Disorder Treatment

    • Other contracted prescribing entity
    • No formal relationship with prescribing entity
    • In-network prescribing entity

    Treatment Approaches

    • Matrix Model
    • Relapse prevention
    • Motivational interviewing
    • Contingency management/motivational incentives
    • Telemedicine/telehealth therapy
    • Substance use disorder counseling

    Facility Operation (e.g., Private, Public)

    • Private for-profit organization

    Facility Vaping Policy

    • Vaping permitted in designated area

    Transitional Services

    • Aftercare/continuing care
    • Discharge Planning
    • Outcome follow-up after discharge
    • Naloxone and overdose education

    Testing

    • Breathalyzer or blood alcohol testing
    • Drug or alcohol urine screening

    Type of Care

    • Substance use treatment
    • Treatment for co-occurring substance use plus either serious mental health illness in adults/serious emotional disturbance in children

    Opioid Medications used in Treatment

    • Naltrexone used in Treatment
    • Buprenorphine used in Treatment

    Pharmacotherapies

    • Buprenorphine without naloxone
    • Acamprosate (CampralĀ®)
    • Naltrexone (oral)
    • Disulfiram
    • Buprenorphine with naloxone
    • Non-nicotine smoking/tobacco cessation
    • Nicotine replacement

    Payment/Insurance/Funding Accepted

    • Federal military insurance (e.g., TRICARE)
    • State-financed health insurance plan other than Medicaid
    • Medicaid
    • Cash or self-payment
    • Private health insurance

    Type of Alcohol Use Disorder Treatment

    • Accepts clients using medication assisted treatment for alcohol use disorder but prescribed elsewhere
    • This facility administers/prescribes medication for alcohol use disorder

    Facility Smoking Policy

    • Smoking permitted in designated area
Opening Hours
Monday
6:00 am - 10:00 pm
Tuesday
6:00 am - 10:00 pm
Wednesday
6:00 am - 10:00 pm
Thursday
6:00 am - 10:00 pm
Friday
6:00 am - 10:00 pm
Saturday
6:00 am - 10:00 pm
Sunday
6:00 am - 10:00 pm